Volcano Corporation Announces Agreement To Acquire AtheroMed
Volcano Corporation Announces Agreement To Acquire AtheroMed Company’s Phoenix Atherectomy System Expands Volcano’s Portfolio Of Peripheral Therapeutic Devices PR Newswire SAN DIEGO, May 27, 2014 SAN DIEGO , May 27, 2014 /PRNewswire/ — Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement to acquire AtheroMed, Inc., a privately-held company that has developed the Phoenix Atherectomy System used in the treatment of peripheral artery disease (PAD). The Phoenix , which received 510(k) clearance in January 2014 and has a CE Mark, enables physicians to treat PAD with a low profile peripheral atherectomy catheter that continuously removes diseased material as it is debulked. The device has reimbursement in the U.S. […]